While GLP-1 agonists have been shown to have central nervous system action, another possible mechanism is slowed gastric emptying 32,33,34 , which could increase fullness and reduce alcohol consumption
This fatigue is a widespread, yet manageable, side effect
Source: FMI analysis, 2026
Collectively, this tri-peptide formulation provides a multifaceted approach to studying regeneration, inflammation resolution, and extracellular matrix restoration in preclinical models GLP-1 10mg Summary Description: Semaglutide is a synthetic, long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA) used primarily for the treatment of type 2 diabetes and, at higher doses, for chronic weight management in adults with overweight or obesity
The trial methodology employed rigorous standards for identifying and categorizing adverse events